BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16607626)

  • 1. Optimal two-stage genotyping designs for genome-wide association scans.
    Wang H; Thomas DC; Pe'er I; Stram DO
    Genet Epidemiol; 2006 May; 30(4):356-68. PubMed ID: 16607626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal robust two-stage designs for genome-wide association studies.
    Nguyen TT; Pahl R; Schäfer H
    Ann Hum Genet; 2009 Nov; 73(Pt 6):638-51. PubMed ID: 19839987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal designs for two-stage genome-wide association studies.
    Skol AD; Scott LJ; Abecasis GR; Boehnke M
    Genet Epidemiol; 2007 Nov; 31(7):776-88. PubMed ID: 17549752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Including sampling and phenotyping costs into the optimization of two stage designs for genomewide association studies.
    Müller HH; Pahl R; Schäfer H
    Genet Epidemiol; 2007 Dec; 31(8):844-52. PubMed ID: 17549751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal multistage designs--a general framework for efficient genome-wide association studies.
    Pahl R; Schäfer H; Müller HH
    Biostatistics; 2009 Apr; 10(2):297-309. PubMed ID: 19075295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward genome-wide SNP genotyping.
    Syvänen AC
    Nat Genet; 2005 Jun; 37 Suppl():S5-10. PubMed ID: 15920530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies.
    Skol AD; Scott LJ; Abecasis GR; Boehnke M
    Nat Genet; 2006 Feb; 38(2):209-13. PubMed ID: 16415888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study designs for genome-wide association studies.
    Kraft P; Cox DG
    Adv Genet; 2008; 60():465-504. PubMed ID: 18358330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The TaqMan method for SNP genotyping.
    Shen GQ; Abdullah KG; Wang QK
    Methods Mol Biol; 2009; 578():293-306. PubMed ID: 19768602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of the stepwise focusing method to optimize the cost-effectiveness of genome-wide association studies with limited research budgets for genotyping and phenotyping.
    Ohashi J; Clark AG
    Ann Hum Genet; 2005 May; 69(Pt 3):323-8. PubMed ID: 15845036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal selection of markers for validation or replication from genome-wide association studies.
    Greenwood CM; Rangrej J; Sun L
    Genet Epidemiol; 2007 Jul; 31(5):396-407. PubMed ID: 17410553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of genome-wide power of genetic association studies based on empirical data from the HapMap project.
    Nannya Y; Taura K; Kurokawa M; Chiba S; Ogawa S
    Hum Mol Genet; 2007 Oct; 16(20):2494-505. PubMed ID: 17666406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for genome-wide association studies: optimization of study designs by the stepwise focusing method.
    Saito A; Kamatani N
    J Hum Genet; 2002; 47(7):360-5. PubMed ID: 12111370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Singleton SNPs in the human genome and implications for genome-wide association studies.
    Ke X; Taylor MS; Cardon LR
    Eur J Hum Genet; 2008 Apr; 16(4):506-15. PubMed ID: 18197193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis in genome-wide association datasets: strategies and application in Parkinson disease.
    Evangelou E; Maraganore DM; Ioannidis JP
    PLoS One; 2007 Feb; 2(2):e196. PubMed ID: 17332845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Universal false discovery rate estimation methodology for genome-wide association studies.
    Forner K; Lamarine M; Guedj M; Dauvillier J; Wojcik J
    Hum Hered; 2008; 65(4):183-94. PubMed ID: 18073488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 100K genome-wide association scan for diabetes and related traits in the Framingham Heart Study: replication and integration with other genome-wide datasets.
    Florez JC; Manning AK; Dupuis J; McAteer J; Irenze K; Gianniny L; Mirel DB; Fox CS; Cupples LA; Meigs JB
    Diabetes; 2007 Dec; 56(12):3063-74. PubMed ID: 17848626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotyping platforms for mass-throughput genotyping with SNPs, including human genome-wide scans.
    Maresso K; Broeckel U
    Adv Genet; 2008; 60():107-39. PubMed ID: 18358318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detailed analysis of the relative power of direct and indirect association studies and the implications for their interpretation.
    Moskvina V; O'Donovan MC
    Hum Hered; 2007; 64(1):63-73. PubMed ID: 17483598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of potential power gain with imputed genotypes in genome-wide association studies.
    Becker T; Flaquer A; Brockschmidt FF; Herold C; Steffens M
    Hum Hered; 2009; 68(1):23-34. PubMed ID: 19339783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.